In this episode, Dr Yassir Javaid and Dr Janaka Karalliedde discuss the broad benefits of SGLT2 inhibitors from a cardio, renal and metabolic perspective and their impact on people living with type 2 diabetes.

In this episode, Dr Kevin Fernando and Alia Gilani talk about the evidence for SGLT2 inhibitors in providing long-term outcomes for people living with type 2 diabetes.